A Study in Patients With Major Depressive Disorder
NCT03642964
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG:
CTC-501
Sponsor
Chase Therapeutics Corporation